NDC 37205-874-71 - LEADER Chest Congestion Relief PE

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
37205-874
Requested NDC
37205-874-71
Package NDCs from labels
37205-874-71, 37205-874-01
Manufacturer
Cardinal Health | Reese Pharmaceutical Co
Effective date
2011-01-26
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
LEADER Chest Congestion Relief PE - Cardinal Health | Reese Pharmaceutical CoCardinal Health | Reese Pharmaceutical Co2011-01-26HUMAN OTC DRUG LABEL
National Council for Prescription Drug Programs indexing - billing unitNational Council for Prescription Drug Programs2012-07-24Indexing - Billing Unit

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
37205-874-012025-04-28C16284748780-19d75b9d1-0d83-f424-e053-dadaa90a57ceDRUG FACTS
37205-874-012020-01-31C16284748780-19d75b9d1-0d83-f424-e053-dadaa90a57ceDRUG FACTS

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
37205-874-71EA - Each37205-874b8520e16-1cb1-44f3-bea5-84ebdc87838512012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
GuaifenesinACTIVE INGREDIENT495W7451VQLEADER CHEST CONGESTION RELIEF PE (GUAIFENESIN/PHENYLEPHRINE) TABLET [CARDINAL HEALTH]1
PHENYLEPHRINE HYDROCHLORIDEACTIVE INGREDIENT04JA59TNSJLEADER CHEST CONGESTION RELIEF PE (GUAIFENESIN/PHENYLEPHRINE) TABLET [CARDINAL HEALTH]1
GuaifenesinACTIVE MOIETY495W7451VQLEADER CHEST CONGESTION RELIEF PE (GUAIFENESIN/PHENYLEPHRINE) TABLET [CARDINAL HEALTH]1
PHENYLEPHRINEACTIVE MOIETY1WS297W6MVLEADER CHEST CONGESTION RELIEF PE (GUAIFENESIN/PHENYLEPHRINE) TABLET [CARDINAL HEALTH]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61ULEADER CHEST CONGESTION RELIEF PE (GUAIFENESIN/PHENYLEPHRINE) TABLET [CARDINAL HEALTH]1
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48LEADER CHEST CONGESTION RELIEF PE (GUAIFENESIN/PHENYLEPHRINE) TABLET [CARDINAL HEALTH]1
LACTOSEINACTIVE INGREDIENTJ2B2A4N98GLEADER CHEST CONGESTION RELIEF PE (GUAIFENESIN/PHENYLEPHRINE) TABLET [CARDINAL HEALTH]1
MAGNESIUM SILICATEINACTIVE INGREDIENT9B9691B2N9LEADER CHEST CONGESTION RELIEF PE (GUAIFENESIN/PHENYLEPHRINE) TABLET [CARDINAL HEALTH]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30LEADER CHEST CONGESTION RELIEF PE (GUAIFENESIN/PHENYLEPHRINE) TABLET [CARDINAL HEALTH]1
MALTODEXTRININACTIVE INGREDIENT7CVR7L4A2DLEADER CHEST CONGESTION RELIEF PE (GUAIFENESIN/PHENYLEPHRINE) TABLET [CARDINAL HEALTH]1
MINERAL OILINACTIVE INGREDIENTT5L8T28FGPLEADER CHEST CONGESTION RELIEF PE (GUAIFENESIN/PHENYLEPHRINE) TABLET [CARDINAL HEALTH]1
POVIDONEINACTIVE INGREDIENTFZ989GH94ELEADER CHEST CONGESTION RELIEF PE (GUAIFENESIN/PHENYLEPHRINE) TABLET [CARDINAL HEALTH]1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 77 of 123 · 2,454 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MUCUS RELIEF DMGUAIFENESIN AND DEXTROMETHORPHAN HBRHarris Teeter17eee39b-5a7a-ba20-e063-6294a90ac3922025-04-29WarningsExact identifier
unii: 495W7451VQ
Mucus Relief DMGUAIFENESIN AND DEXTROMETHORPHAN HBRHarris Teeter826d9c3c-7535-48bb-906e-d75e2ec670db2025-04-29WarningsExact identifier
unii: 495W7451VQ
ff239cc9-2d2c-4eeb-ab96-7c32040447d7171fe7a3-bdc4-44d3-a778-f600ad167f1b2025-04-24WarningsExact identifier
spl set id: 171fe7a3-bdc4-44d3-a778-f600ad167f1b
GuaifenesinGUAIFENESINAMERISOURCE BERGENd1d94d37-4423-4914-9d86-c5ca6d5122f62025-04-22WarningsExact identifier
unii: 495W7451VQ
Mucus Relief Extended ReleaseGUAIFENESINRugby Laboratories, Inc.8bc6f08e-a941-4fa8-8dd6-a699abf2337d2025-04-21WarningsExact identifier
unii: 495W7451VQ
PREPARATION HPHENYLEPHRINE HYDROCHLORIDEHaleon US Holdings LLC96d2e0e7-2de0-4660-9ffd-9edb2ad224d82025-04-18WarningsExact identifier
unii: 04JA59TNSJ
Mineral OilMINERAL OILAmerisourceBergen (Good Neighbor Pharmacy) 46122581f81a0-7488-4c90-b33e-06c6301a4fd22025-04-17WarningsExact identifier
unii: T5L8T28FGP
Mucus ReliefGUAIFENESINLEADER/ Cardinal Health 110, Inc.3099ac87-e61f-2f56-e063-6294a90aa8912025-04-16WarningsExact identifier
unii: 495W7451VQ
MUCUS RELIEFGUAIFENESIN 400 MGPioneer Life Sciences, LLC729ab412-f30b-4ad1-9d8f-1a5e1c48b1182025-04-16WarningsExact identifier
unii: 495W7451VQ
Advil Allergy and Congestion ReliefCHLORPHENIRAMINE MALEATE, IBUPROFEN, AND PHENYLEPHRINE HYDROCHLORIDEHaleon US Holdings LLCa6cc97d8-252a-4527-a470-6d9e356342fd2025-04-09WarningsExact identifier
unii: 04JA59TNSJ
Guaifenesin and Dextromethorphan HBrGUAIFENESIN AND DEXTROMETHORPHAN HBRAurohealth LLC02d2a5a6-36bb-45b5-aba7-779615b276ed2025-04-05WarningsExact identifier
unii: 495W7451VQ
Cough and CongestionDEXTROMETHORPHAN HBR, GUAIFENESINCVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED44fb27d3-5125-4511-84d2-76555bc46e662025-04-03WarningsExact identifier
unii: 495W7451VQ
GuaifenesinGUAIFENESINKESIN PHARMA CORPORATION31b8ad0a-3637-03db-e063-6394a90acdc32025-04-01WarningsExact identifier
unii: 495W7451VQ
MUCUS RELIEFGUAIFENESINBi-Martd995a6a5-d68b-44e4-9281-32c5417fb5e32025-04-01WarningsExact identifier
unii: 495W7451VQ
Phenylephrine HydrochloridePHENYLEPHRINE HYDROCHLORIDEAlcon Laboratories, Inc.cacbb3fd-1c03-4523-a1bf-0ccc4be102ef2025-04-01Warnings, Adverse reactionsExact identifier
unii: 04JA59TNSJ
hemorrhoidalMINERAL OIL, PETROLATUM, PHENYLEPHRINE HCLBionpharma Inc.1790da99-2a22-e2a2-e063-6394a90ac36f2025-03-31WarningsExact identifier
unii: T5L8T28FGP
unii: 04JA59TNSJ
GuaifenesinGUAIFENESINBryant Ranch Prepack570a71eb-2d19-4c7b-8c00-e1524bfa38442025-03-31WarningsExact identifier
unii: 495W7451VQ
GuaifenesinGUAIFENESINKESIN PHARMA CORPORATION365c01b7-a197-4876-85fc-42204f787e3a2025-03-28WarningsExact identifier
unii: 495W7451VQ
SUPRESS-PE PediatricGUIAFENESIN, PHENYLEPHRINE HCLKramer Novisa474171d-5c29-4a80-9d37-00613796211a2025-03-26WarningsExact identifier
unii: 04JA59TNSJ
unii: 495W7451VQ
Guaifenesin DMDEXTROMETHORPHAN HYDROBROMIDE,GUAIFENESINInnovida Pharmaeutique Corporationdd3f806b-2470-4055-94e1-18adac8110252025-03-25WarningsExact identifier
unii: 495W7451VQ

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.